UPDATE: JPMorgan Downgrades Aligos Therapeutics Inc. (ALGS) to Neutral

January 7, 2022 4:19 AM EST Send to a Friend
(Updated - January 7, 2022 4:40 AM EST)

JPMorgan analyst Eric Joseph downgraded Aligos Therapeutics Inc. (NASDAQ: ALGS) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login